0
Article |

AN EXPERIMENTAL STUDY OF THE PROPHYLAXIS OF SYPHILIS WITH ARSPHENAMIN, NEO-ARSPHENAMIN AND SULPHARSPHENAMIN

SIGMUND S. GREENBAUM, M.D.; MALCOLM J. HARKINS, V.M.D.
Arch Derm Syphilol. 1924;10(4):409-413. doi:10.1001/archderm.1924.02360280003001.
Text Size: A A A
Published online

A number of clinical reports have appeared in the literature urging the immediate administration (single dose) of arsphenamin or neo-arsphenamin to persons exposed within twenty-four hours or less to syphilitic infection. Regarding the value of this practice, syphilologists are not in general accord. Michel and Goodman1 were the first American authors to advocate the use of the arsphenamin in this manner. In the foreign literature, two human experimental inoculations and their abortion (one with arsphenamin and the other with the sodium salt of the acetyl derivative of oxyaminophenyl arsinic acid) are recorded. Dr. Magian,2 in order to establish the value of arsenical injections in the prevention of systematization of Spirochaeta pallida, inoculated himself on the forearm with serum obtained from a primary lesion and containing, on dark-field examination, a large number of spirochetes. One hour later, he took an intravenous injection of 0.6 gm. arsphenamin. On subsequent observation,

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs